Immuron IMRN
NASDAQ IMRN
$1.77 -0.07 (-3.80%)
As of: Sep 9, 2026 · 3:59 PM EDT

Immuron (IMRN) Total Liabilities (2015 - 2026)

Immuron (IMRN) posted Total Liabilities of $2.0 million for Q3 2026, down 3.6% on a QoQ basis from $2.1 million in Q4 2025, and up 9540.36% year-over-year from $20607.9 in Q3 2025.

Analysis

Immuron (IMRN) Total Liabilities (2015 - 2026) Analysis & Trends

Immuron has reported Total Liabilities for 12 years, with the latest figure at $2.0 million in Q3 2026.

  • On a quarterly basis, Total Liabilities rose 9540.36% year-over-year to $2.0 million in Q3 2026; TTM through Aug 2026 was $2.0 million, a 9540.36% increase from a year earlier, with the FY2026 full-year figure at $2.0 million, up 9540.36% from the prior year.
  • Total Liabilities was $2.0 million for Q3 2026 at Immuron, down from $2.1 million in the prior quarter.
  • The five-year high for Total Liabilities was $2.1 million in Q4 2025, with the low at -$16.1 million in Q3 2022.
  • Average Total Liabilities over 5 years is -$1.3 million, with a median of $608752.0 recorded in 2025.
  • The sharpest annual moves came in 2025 and 2026: Total Liabilities fell 29.5% in 2025, then soared 9540.36% in 2026.
  • Over 5 years, Total Liabilities stood at $12066.4 in 2022, then increased by 27.12% to $15338.6 in 2023, then surged by 7703.14% to $1.2 million in 2024, then soared by 72.18% to $2.1 million in 2025, then declined by 3.6% to $2.0 million in 2026.
  • The last three Total Liabilities figures came in at $2.0 million (Q3 2026), $2.1 million (Q4 2025), and $20607.9 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 83.95 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 37.53 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 7.18 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 10.02 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn 1.62 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 4.20 Bn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 4.20 Bn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 13.24 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 1.35 Bn
10 Immuron 10.53 Mn 1.51 Mn - 1.99 Mn
Historic Data

Historic Data

Download Data
DateValue
Aug 28, 2026 1.99 Mn
Dec 31, 2025 2.06 Mn
Sep 2, 2025 20,607.86
Jun 30, 2025 1.32 Mn
Dec 31, 2024 1.20 Mn
Sep 9, 2024 18,927.41
Jun 30, 2024 1.87 Mn
Dec 31, 2023 15,338.64
Sep 28, 2023 -12.86 Mn
Aug 30, 2023 -196,168.36
Jun 30, 2023 1.58 Mn
Dec 31, 2022 12,066.37
Aug 31, 2022 -16.12 Mn
Jun 30, 2022 1.20 Mn
Dec 31, 2021 8,781.48
Sep 30, 2021 -19.04 Mn
Jun 30, 2021 891,761.59
Dec 31, 2020 -4.13 Mn
Sep 1, 2020 554,092.00
Jun 30, 2020 365,888.56